Targeting inflammasomes as an immunotherapeutic strategy for cancer
Abstract Inflammasomes are essential regulators of innate immunity, inflammation, and cellular apoptosis, and they have surfaced as significant modulators of cancer progression and regulation. Inflammasomes are macromolecular complexes assembled in response to damage-associated molecular patterns (D...
Saved in:
| Main Authors: | Luanluan Huang, Xiaoyan Chen, Ruiqi Liu, Ding Nan, Wenxuan Bao, Lixian Yang, Xiaomeng Dai, Jianming Tang, Haibo Zhang, Yanwei Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06665-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential
by: Vivek Singh, et al.
Published: (2025-03-01) -
Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
by: Benjamin Koh, et al.
Published: (2023-12-01) -
Integrative multi-omic analysis of NLRP3 inflammasome dysregulation and subtyping for personalized treatment in acute myeloid leukemia
by: Hong Zhang, et al.
Published: (2025-07-01) -
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
by: Christin Knickmeier, et al.
Published: (2025-01-01) -
Oligodendroglioma: Advances in Molecular Mechanisms and Immunotherapeutic Strategies
by: Yongxin Zhao, et al.
Published: (2025-05-01)